Semaglutide (GLP-1)

Semaglutide acts on the GLP-1 receptor and can help reduce appetite and food intake. A clinician can discuss whether a prescription weight loss treatment is appropriate for your medical history and goals.

Injection and oral treatment options may differ in how they are used and who qualifies. Your clinician will explain the available options during your consultation.

Tirzepatide (GIP/GLP-1)

Tirzepatide acts on both GIP and GLP-1 receptors. It is given as a once-weekly injection when prescribed for an eligible patient, alongside changes in nutrition and activity.

We’ll review your health history, discuss expected benefits and possible side effects, and help you understand your treatment choices.

Retatrutide (GLP-3)

Retatrutide is an investigational medication that acts on GIP, GLP-1, and glucagon receptors. Researchers are studying it for weight management.

Retatrutide is not yet FDA-approved.

Peptides

Explore peptide options and learn how they may fit into a medically guided wellness plan. Your clinician can discuss individual peptides, their potential uses, and whether any option is appropriate for you.